封面
市場調查報告書
商品編碼
2166758

獸用聯合及多價疫苗市場:全球市場預測,2026-2032年

Veterinary Combination Vaccine & Multivalent Vaccine Market - Global Forecast 2026-2032

出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年,獸用聯合疫苗和多價疫苗市場將成長至 187.7 億美元,複合年成長率為 7.94%。

主要市場統計數據
基準年 2025 109.9億美元
預計年份:2026年 119.1億美元
預測年份 2032 187.7億美元
複合年成長率 (%) 7.94%

獸用聯合疫苗與多價疫苗:概述

獸用聯合疫苗和多價疫苗整合了對多種病原體的保護,並減少了伴侶動物、家畜和水產養殖動物所需的疫苗接種次數。它們的價值體現在疾病預防、提高疫苗接種依從性、提升營運效率、保障動物福利、減少生產中斷等。疫苗的推廣應用趨勢受多種因素影響,包括病原體流行情況、獸醫基礎設施、監管要求、冷鏈可靠性、診斷能力以及對疫苗安全性和有效性的信心。

預防工作正朝著綜合性的、以專案為基礎的保護方向發展。

目前的趨勢是從針對單一疾病的干預措施轉向根據物種、年齡、地區、生產系統和暴露風險量身定做的疫苗接種方案。聯合疫苗可以簡化接種程序,並有助於提高獸醫資源匱乏地區的疫苗接種率,而多價疫苗則有助於應對同時流行的病原體。此外,人們也越來越重視動物管理、監測、可追溯性、疫苗接種後監測以及盡量減少不必要的動物操作。

人工智慧增強了監測、藥物研發和管理方面的決策能力。

人工智慧可以透過識別臨床記錄、實驗室結果、動物流動數據和農場層面的觀察數據中的疾病徵兆,為改進獸醫疫苗接種計劃做出貢獻。預測工具可以輔助基於風險的疫苗接種計劃、冷鏈監測、不利事件檢測以及診斷測試的優先排序。在研發領域,機器學習可以輔助抗原選擇和配方分析,但其應用需要具有代表性的資料集、透明的檢驗、網路安全以及持續的專家監督。人工智慧應作為獸醫判斷或監管審查的補充,而非替代。

區域洞察:基礎設施和疾病威脅驅動部署

在北美,成熟的獸醫服務、完善的伴侶動物照護體系和先進的畜牧生物安全措施,共同支持對便利、實證疫苗接種方案的需求。拉丁美洲的實施則受到商業性畜牧系統、通用感染疾病應對優先事項、經濟負擔以及獸醫服務可近性差異的影響。在歐洲,監管合規、動物福利、監測和統一的疾病管制措施備受重視。在中東,需要針對跨國動物流動、氣候壓力和畜牧健康優先事項量身定做的解決方案。同時,由於獸醫服務可近性、遊牧業、地方性疾病負擔以及冷鏈限制等因素,非洲的需求差異顯著。在亞太地區,集約化畜牧業、水產養殖、伴侶動物以及快速發展的獸醫系統都存在著不同的需求,各國的生產和分銷能力也存在顯著差異。

集團洞察:貿易、監管和安全網路的重要性

東協市場受惠於跨境動物疫病合作,但其具體實施情況因獸醫系統和島嶼及當地物流而異。金磚國家成員國擁有主要的畜牧業、伴侶動物和疫苗生產基地,這為協調監測提供了機遇,同時又能維持各自的監管路徑。歐盟支持在授權、監測和動物健康方面遵循通用原則,但各國的具體實施方法仍然至關重要。七國集團(G7)國家在調查、診斷和監管方面普遍擁有強大的能力,尤其注重產品品質和抗菌藥物的合理使用。海灣合作理事會(GCC)市場優先考慮進口可靠性、牲畜保護和適應氣候變遷的獸醫服務。北約成員國在生物安全和跨境緊急準備方面發揮重要作用,包括在緊急情況下確保動物健康供應鏈的連續性。

國家概況:15個國內市場的多元化優先事項

澳洲優先考慮畜牧生物安全、牧場放養生產系統以及防止外來疾病傳入。巴西將大規模畜牧養殖與嚴格的畜群健康管理、可追溯性和出口導向疾病控制要求相結合。加拿大和美國利用先進的獸醫網路,同時兼顧區域生產差異和伴侶動物需求。中國和印度需要適合大型且多樣化畜群的解決方案,擴大獸醫服務的可及性,並適應不同的監管和分銷條件。日本和韓國強調以法規為基礎的動物健康、疾病預防和技術驅動的醫療服務。法國、德國、義大利和西班牙在歐洲法規結構內運作,同時體現了各自在畜牧業、伴侶動物和區域疾病控制方面的優先事項。英國根據不斷變化的貿易和法規環境,維持嚴格的生物安全和監測要求。墨西哥的優先事項包括畜牧生產力、邊境疾病管制以及不同農業系統的進入。俄羅斯的動物健康計畫受到國內生產、區域疾病模式和供應鏈韌性的影響。

領導者行動指南:建立證據、韌性和專案適應性

產業領導者不應將聯合疫苗歸為單一類別,而應根據目標動物種類、病原體特徵、生產模式和獸醫可及性進行分類。他們也應建立安全性、免疫抗原性、保護期、簡化免疫程序和現場表現的比較證據,並輔以透明的上市後監測。分銷策略應加強冷鏈可視性、現場培訓、庫存彈性以及數位化可追溯性。與獸醫、生產商、診斷實驗室、監管機構和公共衛生部門夥伴關係將有助於提高疫苗的普及率和信任度。人工智慧的投資應基於明確控制的應用案例、檢驗的數據、人工審核和可衡量的營運結果。

調查方法:基於證據的市場結構分析(消除未經證實的量化)

本執行摘要採用結構化的質性架構分析獸用聯合疫苗和多價疫苗。它評估了產品效用、疾病預防需求、目標物種、監管和監測環境、獸醫基礎設施、物流以及區域商業環境。摘要整合了區域、群體和國家觀點,並設定了特定的地理範圍,圍繞著可觀察的產業促進因素和限制因素。摘要中未使用任何市場估算、預測或公司特定聲明。在做出策略決策之前,應根據目前的監管文件、獸醫疾病監測數據、同行評審的證據以及現場績效數據檢驗結論。

結論:綜合疫苗接種有助於提高動物健康計畫的效率。

獸用聯合疫苗和多價疫苗處於疾病預防、動物福利、生產連續性和獸醫實際應用的關鍵交會點。其有效性不僅取決於配方,還取決於監測、診斷、監管、冷鏈運作、專家信心以及與當地免疫接種計劃的兼容性。那些將嚴謹的實證實踐與在地化實施方案、穩健的供應鏈以及負責任的數位化工具相結合的領導者,將更有能力在不同市場中提升動物健康水平。

目錄

第1章:序言

第2章:調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章:人工智慧的累積影響,2026年

第7章 獸用聯合疫苗和多價疫苗市場:依動物類型分類

  • 水生動物
  • 伴侶動物
    • 貓
    • 狗
  • 馬
  • 家畜
    • 牛
    • 家禽
    • 綿羊/山羊
    • 豬
  • 野生動物
    • 鹿
    • 毛皮動物

第8章 獸用聯合疫苗與多價疫苗市場:依產品類型分類

  • 結合疫苗
  • 去活化疫苗
  • 減毒活疫苗
  • 重組疫苗
  • 類毒素疫苗

第9章 獸用聯合疫苗及多價疫苗市場:依給藥途徑分類

  • 肌肉內部
  • 鼻內給藥
  • 口服
  • 皮下

第10章 獸用聯合疫苗和多價疫苗市場:依最終用戶分類

  • 畜牧場
    • 牛
    • 家禽養殖場
    • 養豬場
  • 研究機構
  • 獸醫醫院和診所

第11章 獸用聯合疫苗與多價疫苗市場:依通路分類

  • 直銷
  • 銷售代理
  • 線上

第12章 獸用聯合及多價疫苗市場:依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章 獸用聯合及多價疫苗市場:依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 獸用聯合疫苗和多價疫苗市場:依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2025年市佔率分析
  • 市場集中度分析,2025年
    • 濃度比(CR)
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析,2025 年
  • 2025年產品系列分析
  • 基準分析,2025 年

第16章:公司簡介

  • Bimeda Biologicals
  • Biogenesis Bago SA
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • Hester Biosciences Limited
  • HIPRA, SA
  • Huvepharma, Inc.
  • Indian Immunologicals Limited
  • Merck & Co., Inc.
  • Phibro Animal Health Corporation
  • Vaxxinova
  • Virbac SA
  • Zoetis Inc.

第17章 主要專家

Product Code: MRR-1F6B55428652

The Veterinary Combination Vaccine & Multivalent Vaccine Market is projected to grow by USD 18.77 billion at a CAGR of 7.94% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 10.99 billion
Estimated Year [2026] USD 11.91 billion
Forecast Year [2032] USD 18.77 billion
CAGR (%) 7.94%

Veterinary Combination and Multivalent Vaccines: Executive Overview

Veterinary combination and multivalent vaccines consolidate protection against multiple pathogens into fewer administrations for companion animals, livestock, and aquaculture. Their value is linked to disease prevention, vaccination compliance, operational efficiency, animal welfare, and reduced production disruption. Adoption is shaped by pathogen prevalence, veterinary infrastructure, regulatory requirements, cold-chain reliability, diagnostic capacity, and confidence in vaccine safety and effectiveness.

Prevention Is Shifting Toward Integrated, Program-Based Protection

The landscape is moving from single-disease interventions toward coordinated vaccination programs aligned with species, age, geography, production systems, and exposure risk. Combination products can simplify schedules and support coverage where veterinary access is constrained, while multivalent formulations help address co-circulating pathogens. Greater attention is also being placed on stewardship, surveillance, traceability, post-vaccination monitoring, and minimizing unnecessary handling of animals.

Artificial Intelligence Strengthens Surveillance, Formulation, and Delivery Decisions

Artificial intelligence can improve veterinary vaccine programs by identifying disease signals from clinical records, laboratory results, mobility data, and farm-level observations. Predictive tools may support risk-based vaccination planning, cold-chain monitoring, adverse-event detection, and prioritization of diagnostic testing. In research and development, machine learning can assist antigen selection and formulation analysis, but deployment requires representative datasets, transparent validation, cybersecurity, and continued expert oversight. AI should augment-not replace-veterinary judgment and regulatory review.

Regional Insights: Infrastructure and Disease Pressure Shape Adoption

North America combines mature veterinary services, established companion-animal care, and sophisticated livestock biosecurity, supporting demand for convenient and evidence-based vaccination schedules. Latin America's adoption is influenced by commercial livestock systems, zoonotic-disease priorities, affordability, and uneven access to veterinary services. Europe emphasizes regulatory compliance, animal welfare, surveillance, and harmonized disease-control practices. The Middle East requires solutions adapted to cross-border animal movement, climatic stress, and livestock health priorities, while Africa's needs vary widely with veterinary access, mobile herds, endemic disease burden, and cold-chain limitations. Asia-Pacific presents diverse requirements across intensive livestock, aquaculture, companion animals, and rapidly developing veterinary systems, with manufacturing and distribution capacity differing substantially by country.

Group Insights: Trade, Regulation, and Security Networks Matter

ASEAN markets benefit from cooperation on transboundary animal diseases, but implementation differs across veterinary systems and island or mainland logistics. BRICS members span major livestock, companion-animal, and vaccine-manufacturing environments, creating opportunities for coordinated surveillance while retaining distinct regulatory pathways. The European Union supports common principles for authorization, surveillance, and animal health, although national delivery practices remain important. G7 countries generally have strong research, diagnostic, and regulatory capabilities, with emphasis on product quality and antimicrobial stewardship. GCC markets prioritize import reliability, livestock protection, and climate-adapted veterinary services. NATO members are relevant to biosecurity and cross-border preparedness, including continuity of animal-health supply chains during emergencies.

Country Insights: Diverse Priorities Across Fifteen National Markets

Australia emphasizes livestock biosecurity, extensive production systems, and protection from exotic disease incursions. Brazil combines large-scale animal production with strong requirements for herd health, traceability, and export-oriented disease control. Canada and the United States rely on advanced veterinary networks while addressing regional production differences and companion-animal demand. China and India require solutions suited to large and diverse livestock populations, expanding veterinary access, and varied regulatory and distribution conditions. Japan and South Korea place emphasis on regulated animal health, disease prevention, and technologically enabled care. France, Germany, Italy, and Spain operate within European regulatory frameworks while reflecting distinct livestock, companion-animal, and regional disease priorities. The United Kingdom maintains strong biosecurity and surveillance requirements following changes to its trading and regulatory environment. Mexico's priorities include livestock productivity, border-related disease control, and access across varied farming systems. Russia's animal-health planning is influenced by domestic production, regional disease patterns, and supply-chain resilience.

Actions for Leaders: Build Evidence, Resilience, and Program Fit

Industry leaders should segment products and services by species, pathogen profile, production model, and veterinary-access conditions rather than treating combination vaccination as a uniform category. They should generate comparative evidence on safety, immunogenicity, duration of protection, schedule simplification, and field performance, supported by transparent post-market surveillance. Distribution strategies should strengthen cold-chain visibility, local training, inventory resilience, and digital traceability. Partnerships with veterinarians, producers, diagnostic laboratories, regulators, and public-health authorities can improve uptake and trust. AI investments should begin with clearly governed use cases, validated data, human review, and measurable operational outcomes.

Research Methodology: Evidence-Based Market Structuring Without Unsupported Quantification

This executive summary uses a structured qualitative framework for veterinary combination and multivalent vaccines. It assesses product utility, disease-prevention needs, species applications, regulatory and surveillance conditions, veterinary infrastructure, logistics, and regional operating environments. Regional, group, and country perspectives are integrated using the specified geographies and are framed around observable industry drivers and constraints. No market estimates, market shares, forecasts, or company-specific claims are used; conclusions should be validated against current regulatory documents, veterinary disease surveillance, peer-reviewed evidence, and field-level performance data before strategic decisions are made.

Conclusion: Integrated Vaccination Supports More Efficient Animal Health Programs

Veterinary combination and multivalent vaccines are positioned at the intersection of disease prevention, animal welfare, production continuity, and practical veterinary delivery. Their effectiveness depends not only on formulation, but also on surveillance, diagnostics, regulation, cold-chain execution, professional confidence, and fit with local vaccination programs. Leaders that combine rigorous evidence with regionally adapted implementation, resilient supply chains, and responsible digital tools will be better placed to strengthen animal-health outcomes across diverse markets.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. New Revenue Opportunities
  • 3.4. Next-Generation Business Models
  • 3.5. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Veterinary Combination Vaccine & Multivalent Vaccine Market, by Animal Type

  • 7.1. Introduction
  • 7.2. Aquatic
  • 7.3. Companion Animals
    • 7.3.1. Cats
    • 7.3.2. Dogs
  • 7.4. Equine
  • 7.5. Livestock
    • 7.5.1. Cattle
    • 7.5.2. Poultry
    • 7.5.3. Sheep & Goat
    • 7.5.4. Swine
  • 7.6. Wildlife
    • 7.6.1. Deer
    • 7.6.2. Furbearers

8. Veterinary Combination Vaccine & Multivalent Vaccine Market, by Product Type

  • 8.1. Introduction
  • 8.2. Conjugate Vaccine
  • 8.3. Inactivated Vaccine
  • 8.4. Live Attenuated Vaccine
  • 8.5. Recombinant Vaccine
  • 8.6. Toxoid Vaccine

9. Veterinary Combination Vaccine & Multivalent Vaccine Market, by Route Of Administration

  • 9.1. Introduction
  • 9.2. Intramuscular
  • 9.3. Intranasal
  • 9.4. Oral
  • 9.5. Subcutaneous

10. Veterinary Combination Vaccine & Multivalent Vaccine Market, by End User

  • 10.1. Introduction
  • 10.2. Animal Farms
    • 10.2.1. Cattle Farms
    • 10.2.2. Poultry Farms
    • 10.2.3. Swine Farms
  • 10.3. Research Institutes
  • 10.4. Veterinary Hospitals & Clinics

11. Veterinary Combination Vaccine & Multivalent Vaccine Market, by Distribution Channel

  • 11.1. Introduction
  • 11.2. Direct Sales
  • 11.3. Distributors
  • 11.4. Online

12. Veterinary Combination Vaccine & Multivalent Vaccine Market, by Region

  • 12.1. Introduction
  • 12.2. Asia-Pacific
  • 12.3. North America
  • 12.4. Latin America
  • 12.5. Europe
  • 12.6. Middle East
  • 12.7. Africa

13. Veterinary Combination Vaccine & Multivalent Vaccine Market, by Group

  • 13.1. Introduction
  • 13.2. ASEAN
  • 13.3. GCC
  • 13.4. European Union
  • 13.5. BRICS
  • 13.6. G7
  • 13.7. NATO

14. Veterinary Combination Vaccine & Multivalent Vaccine Market, by Country

  • 14.1. Introduction
  • 14.2. United States
  • 14.3. Canada
  • 14.4. Mexico
  • 14.5. Brazil
  • 14.6. United Kingdom
  • 14.7. Germany
  • 14.8. France
  • 14.9. Russia
  • 14.10. Italy
  • 14.11. Spain
  • 14.12. China
  • 14.13. India
  • 14.14. Japan
  • 14.15. Australia
  • 14.16. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2025
  • 15.2. Market Concentration Analysis, 2025
    • 15.2.1. Concentration Ratio (CR)
    • 15.2.2. Herfindahl Hirschman Index (HHI)
  • 15.3. Recent Developments & Impact Analysis, 2025
  • 15.4. Product Portfolio Analysis, 2025
  • 15.5. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Bimeda Biologicals
  • 16.2. Biogenesis Bago S.A.
  • 16.3. Boehringer Ingelheim International GmbH
  • 16.4. Ceva Sante Animale
  • 16.5. Dechra Pharmaceuticals PLC
  • 16.6. Elanco Animal Health Incorporated
  • 16.7. Hester Biosciences Limited
  • 16.8. HIPRA, S.A.
  • 16.9. Huvepharma, Inc.
  • 16.10. Indian Immunologicals Limited
  • 16.11. Merck & Co., Inc.
  • 16.12. Phibro Animal Health Corporation
  • 16.13. Vaxxinova
  • 16.14. Virbac S.A.
  • 16.15. Zoetis Inc.

17. Key Experts

LIST OF FIGURES

  • FIGURE 1. Global Veterinary Combination Vaccine & Multivalent Vaccine Market, Years Considered for the Study
  • FIGURE 2. Global Veterinary Combination Vaccine & Multivalent Vaccine Market, Research Design
  • FIGURE 3. Global Veterinary Combination Vaccine & Multivalent Vaccine Market, Research Framework
  • FIGURE 4. Global Veterinary Combination Vaccine & Multivalent Vaccine Market, Data Triangulation
  • FIGURE 5. Global Veterinary Combination Vaccine & Multivalent Vaccine Market Size, 2017-2032 (USD Million)
  • FIGURE 6. Global Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Type, 2025 vs 2032 (%)
  • FIGURE 7. Global Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Type, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 8. Global Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Product Type, 2025 vs 2032 (%)
  • FIGURE 9. Global Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 10. Global Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Route Of Administration, 2025 vs 2032 (%)
  • FIGURE 11. Global Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Route Of Administration, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 12. Global Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by End User, 2025 vs 2032 (%)
  • FIGURE 13. Global Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 14. Global Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Distribution Channel, 2025 vs 2032 (%)
  • FIGURE 15. Global Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 16. Global Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Region, 2025 vs 2032 (%)
  • FIGURE 17. Global Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 18. Global Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 19. Global Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Country, 2025 vs 2032 (%)
  • FIGURE 20. Global Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 21. Global Veterinary Combination Vaccine & Multivalent Vaccine Market Share, by Key Player, 2025

LIST OF TABLES

  • TABLE 1. Global Veterinary Combination Vaccine & Multivalent Vaccine Market Segmentation & Coverage
  • TABLE 2. Global Veterinary Combination Vaccine & Multivalent Vaccine Market Size, 2017-2032 (USD Million)
  • TABLE 3. Global Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 4. Global Aquatic Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 5. Global Aquatic Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 6. Global Aquatic Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 7. Global Companion Animals Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 8. Global Companion Animals Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 9. Global Companion Animals Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 10. Global Cats Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 11. Global Cats Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 12. Global Cats Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 13. Global Dogs Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 14. Global Dogs Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 15. Global Dogs Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 16. Global Equine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 17. Global Equine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 18. Global Equine Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 19. Global Livestock Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 20. Global Livestock Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 21. Global Livestock Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 22. Global Cattle Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 23. Global Cattle Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 24. Global Cattle Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 25. Global Poultry Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 26. Global Poultry Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 27. Global Poultry Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 28. Global Sheep & Goat Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 29. Global Sheep & Goat Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 30. Global Sheep & Goat Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 31. Global Swine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 32. Global Swine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 33. Global Swine Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 34. Global Wildlife Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 35. Global Wildlife Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 36. Global Wildlife Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 37. Global Deer Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 38. Global Deer Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 39. Global Deer Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 40. Global Furbearers Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 41. Global Furbearers Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 42. Global Furbearers Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 43. Global Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 44. Global Conjugate Vaccine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 45. Global Conjugate Vaccine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 46. Global Conjugate Vaccine Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 47. Global Inactivated Vaccine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 48. Global Inactivated Vaccine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 49. Global Inactivated Vaccine Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 50. Global Live Attenuated Vaccine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 51. Global Live Attenuated Vaccine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 52. Global Live Attenuated Vaccine Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 53. Global Recombinant Vaccine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 54. Global Recombinant Vaccine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 55. Global Recombinant Vaccine Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 56. Global Toxoid Vaccine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 57. Global Toxoid Vaccine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 58. Global Toxoid Vaccine Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 59. Global Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 60. Global Intramuscular Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 61. Global Intramuscular Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 62. Global Intramuscular Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 63. Global Intranasal Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 64. Global Intranasal Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 65. Global Intranasal Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 66. Global Oral Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 67. Global Oral Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 68. Global Oral Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 69. Global Subcutaneous Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 70. Global Subcutaneous Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 71. Global Subcutaneous Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 72. Global Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 73. Global Animal Farms Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 74. Global Animal Farms Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 75. Global Animal Farms Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 76. Global Cattle Farms Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 77. Global Cattle Farms Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 78. Global Cattle Farms Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 79. Global Poultry Farms Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 80. Global Poultry Farms Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 81. Global Poultry Farms Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 82. Global Swine Farms Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 83. Global Swine Farms Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 84. Global Swine Farms Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 85. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 86. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 87. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 88. Global Veterinary Hospitals & Clinics Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 89. Global Veterinary Hospitals & Clinics Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 90. Global Veterinary Hospitals & Clinics Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 91. Global Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 92. Global Direct Sales Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 93. Global Direct Sales Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 94. Global Direct Sales Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 95. Global Distributors Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 96. Global Distributors Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 97. Global Distributors Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 98. Global Online Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 99. Global Online Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 100. Global Online Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 101. Global Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 102. Asia-Pacific Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 103. Asia-Pacific Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 104. Asia-Pacific Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Companion Animals, 2017-2032 (USD Million)
  • TABLE 105. Asia-Pacific Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Livestock, 2017-2032 (USD Million)
  • TABLE 106. Asia-Pacific Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Wildlife, 2017-2032 (USD Million)
  • TABLE 107. Asia-Pacific Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 108. Asia-Pacific Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 109. Asia-Pacific Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 110. Asia-Pacific Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Farms, 2017-2032 (USD Million)
  • TABLE 111. Asia-Pacific Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 112. North America Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 113. North America Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 114. North America Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Companion Animals, 2017-2032 (USD Million)
  • TABLE 115. North America Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Livestock, 2017-2032 (USD Million)
  • TABLE 116. North America Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Wildlife, 2017-2032 (USD Million)
  • TABLE 117. North America Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 118. North America Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 119. North America Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 120. North America Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Farms, 2017-2032 (USD Million)
  • TABLE 121. North America Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 122. Latin America Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 123. Latin America Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 124. Latin America Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Companion Animals, 2017-2032 (USD Million)
  • TABLE 125. Latin America Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Livestock, 2017-2032 (USD Million)
  • TABLE 126. Latin America Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Wildlife, 2017-2032 (USD Million)
  • TABLE 127. Latin America Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 128. Latin America Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 129. Latin America Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 130. Latin America Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Farms, 2017-2032 (USD Million)
  • TABLE 131. Latin America Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 132. Europe Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 133. Europe Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 134. Europe Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Companion Animals, 2017-2032 (USD Million)
  • TABLE 135. Europe Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Livestock, 2017-2032 (USD Million)
  • TABLE 136. Europe Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Wildlife, 2017-2032 (USD Million)
  • TABLE 137. Europe Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 138. Europe Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 139. Europe Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 140. Europe Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Farms, 2017-2032 (USD Million)
  • TABLE 141. Europe Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 142. Middle East Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 143. Middle East Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 144. Middle East Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Companion Animals, 2017-2032 (USD Million)
  • TABLE 145. Middle East Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Livestock, 2017-2032 (USD Million)
  • TABLE 146. Middle East Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Wildlife, 2017-2032 (USD Million)
  • TABLE 147. Middle East Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 148. Middle East Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 149. Middle East Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 150. Middle East Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Farms, 2017-2032 (USD Million)
  • TABLE 151. Middle East Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 152. Africa Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 153. Africa Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 154. Africa Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Companion Animals, 2017-2032 (USD Million)
  • TABLE 155. Africa Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Livestock, 2017-2032 (USD Million)
  • TABLE 156. Africa Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Wildlife, 2017-2032 (USD Million)
  • TABLE 157. Africa Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 158. Africa Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 159. Africa Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 160. Africa Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Farms, 2017-2032 (USD Million)
  • TABLE 161. Africa Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 162. Global Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 163. ASEAN Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 164. ASEAN Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 165. ASEAN Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Companion Animals, 2017-2032 (USD Million)
  • TABLE 166. ASEAN Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Livestock, 2017-2032 (USD Million)
  • TABLE 167. ASEAN Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Wildlife, 2017-2032 (USD Million)
  • TABLE 168. ASEAN Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 169. ASEAN Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 170. ASEAN Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 171. ASEAN Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Farms, 2017-2032 (USD Million)
  • TABLE 172. ASEAN Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 173. GCC Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 174. GCC Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 175. GCC Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Companion Animals, 2017-2032 (USD Million)
  • TABLE 176. GCC Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Livestock, 2017-2032 (USD Million)
  • TABLE 177. GCC Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Wildlife, 2017-2032 (USD Million)
  • TABLE 178. GCC Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 179. GCC Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 180. GCC Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 181. GCC Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Farms, 2017-2032 (USD Million)
  • TABLE 182. GCC Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 183. European Union Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 184. European Union Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 185. European Union Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Companion Animals, 2017-2032 (USD Million)
  • TABLE 186. European Union Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Livestock, 2017-2032 (USD Million)
  • TABLE 187. European Union Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Wildlife, 2017-2032 (USD Million)
  • TABLE 188. European Union Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 189. European Union Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 190. European Union Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 191. European Union Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Farms, 2017-2032 (USD Million)
  • TABLE 192. European Union Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 193. BRICS Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 194. BRICS Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 195. BRICS Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Companion Animals, 2017-2032 (USD Million)
  • TABLE 196. BRICS Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Livestock, 2017-2032 (USD Million)
  • TABLE 197. BRICS Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Wildlife, 2017-2032 (USD Million)
  • TABLE 198. BRICS Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 199. BRICS Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 200. BRICS Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 201. BRICS Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Farms, 2017-2032 (USD Million)
  • TABLE 202. BRICS Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 203. G7 Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 204. G7 Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 205. G7 Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Companion Animals, 2017-2032 (USD Million)
  • TABLE 206. G7 Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Livestock, 2017-2032 (USD Million)
  • TABLE 207. G7 Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Wildlife, 2017-2032 (USD Million)
  • TABLE 208. G7 Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 209. G7 Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 210. G7 Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 211. G7 Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Farms, 2017-2032 (USD Million)
  • TABLE 212. G7 Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 213. NATO Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 214. NATO Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 215. NATO Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Companion Animals, 2017-2032 (USD Million)
  • TABLE 216. NATO Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Livestock, 2017-2032 (USD Million)
  • TABLE 217. NATO Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Wildlife, 2017-2032 (USD Million)
  • TABLE 218. NATO Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 219. NATO Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 220. NATO Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 221. NATO Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Farms, 2017-2032 (USD Million)
  • TABLE 222. NATO Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 223. Global Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 224. United States Veterinary Combination Vaccine & Multivalent Vaccine Market Size, 2017-2032 (USD Million)
  • TABLE 225. United States Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 226. United States Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Companion Animals, 2017-2032 (USD Million)
  • TABLE 227. United States Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Livestock, 2017-2032 (USD Million)
  • TABLE 228. United States Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Wildlife, 2017-2032 (USD Million)
  • TABLE 229. United States Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 230. United States Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 231. United States Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 232. United States Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Farms, 2017-2032 (USD Million)
  • TABLE 233. United States Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 234. Canada Veterinary Combination Vaccine & Multivalent Vaccine Market Size, 2017-2032 (USD Million)
  • TABLE 235. Canada Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 236. Canada Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Companion Animals, 2017-2032 (USD Million)
  • TABLE 237. Canada Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Livestock, 2017-2032 (USD Million)
  • TABLE 238. Canada Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Wildlife, 2017-2032 (USD Million)
  • TABLE 239. Canada Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 240. Canada Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 241. Canada Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 242. Canada Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Farms, 2017-2032 (USD Million)
  • TABLE 243. Canada Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 244. Mexico Veterinary Combination Vaccine & Multivalent Vaccine Market Size, 2017-2032 (USD Million)
  • TABLE 245. Mexico Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 246. Mexico Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Companion Animals, 2017-2032 (USD Million)
  • TABLE 247. Mexico Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Livestock, 2017-2032 (USD Million)
  • TABLE 248. Mexico Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Wildlife, 2017-2032 (USD Million)
  • TABLE 249. Mexico Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 250. Mexico Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 251. Mexico Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 252. Mexico Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Farms, 2017-2032 (USD Million)
  • TABLE 253. Mexico Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 254. Brazil Veterinary Combination Vaccine & Multivalent Vaccine Market Size, 2017-2032 (USD Million)
  • TABLE 255. Brazil Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 256. Brazil Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Companion Animals, 2017-2032 (USD Million)
  • TABLE 257. Brazil Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Livestock, 2017-2032 (USD Million)
  • TABLE 258. Brazil Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Wildlife, 2017-2032 (USD Million)
  • TABLE 259. Brazil Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 260. Brazil Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 261. Brazil Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 262. Brazil Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Farms, 2017-2032 (USD Million)
  • TABLE 263. Brazil Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 264. United Kingdom Veterinary Combination Vaccine & Multivalent Vaccine Market Size, 2017-2032 (USD Million)
  • TABLE 265. United Kingdom Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 266. United Kingdom Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Companion Animals, 2017-2032 (USD Million)
  • TABLE 267. United Kingdom Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Livestock, 2017-2032 (USD Million)
  • TABLE 268. United Kingdom Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Wildlife, 2017-2032 (USD Million)
  • TABLE 269. United Kingdom Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 270. United Kingdom Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 271. United Kingdom Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 272. United Kingdom Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Farms, 2017-2032 (USD Million)
  • TABLE 273. United Kingdom Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 274. Germany Veterinary Combination Vaccine & Multivalent Vaccine Market Size, 2017-2032 (USD Million)
  • TABLE 275. Germany Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 276. Germany Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Companion Animals, 2017-2032 (USD Million)
  • TABLE 277. Germany Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Livestock, 2017-2032 (USD Million)
  • TABLE 278. Germany Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Wildlife, 2017-2032 (USD Million)
  • TABLE 279. Germany Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 280. Germany Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 281. Germany Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 282. Germany Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Farms, 2017-2032 (USD Million)
  • TABLE 283. Germany Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 284. France Veterinary Combination Vaccine & Multivalent Vaccine Market Size, 2017-2032 (USD Million)
  • TABLE 285. France Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 286. France Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Companion Animals, 2017-2032 (USD Million)
  • TABLE 287. France Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Livestock, 2017-2032 (USD Million)
  • TABLE 288. France Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Wildlife, 2017-2032 (USD Million)
  • TABLE 289. France Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 290. France Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 291. France Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 292. France Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Farms, 2017-2032 (USD Million)
  • TABLE 293. France Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 294. Russia Veterinary Combination Vaccine & Multivalent Vaccine Market Size, 2017-2032 (USD Million)
  • TABLE 295. Russia Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Ty